PTX
Vanguard Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-90,003
| Closed | -$38K | – | 4189 |
|
2018
Q4 | $38K | Sell |
90,003
-284,214
| -76% | -$120K | ﹤0.01% | 4093 |
|
2018
Q3 | $361K | Hold |
374,217
| – | – | ﹤0.01% | 3904 |
|
2018
Q2 | $909K | Buy |
374,217
+768
| +0.2% | +$1.87K | ﹤0.01% | 3714 |
|
2018
Q1 | $892K | Buy |
373,449
+45,959
| +14% | +$110K | ﹤0.01% | 3670 |
|
2017
Q4 | $786K | Buy |
327,490
+100
| +0% | +$240 | ﹤0.01% | 3663 |
|
2017
Q3 | $1.03M | Sell |
327,390
-75,033
| -19% | -$236K | ﹤0.01% | 3584 |
|
2017
Q2 | $1.62M | Buy |
402,423
+56,182
| +16% | +$226K | ﹤0.01% | 3448 |
|
2017
Q1 | $1.28M | Buy |
346,241
+90,682
| +35% | +$335K | ﹤0.01% | 3520 |
|
2016
Q4 | $496K | Sell |
255,559
-685,596
| -73% | -$1.33M | ﹤0.01% | 3735 |
|
2016
Q3 | $585K | Sell |
941,155
-899,332
| -49% | -$559K | ﹤0.01% | 3722 |
|
2016
Q2 | $824K | Buy |
1,840,487
+43,868
| +2% | +$19.6K | ﹤0.01% | 3661 |
|
2016
Q1 | $1.89M | Buy |
1,796,619
+6,513
| +0.4% | +$6.84K | ﹤0.01% | 3405 |
|
2015
Q4 | $5.28M | Buy |
1,790,106
+50,261
| +3% | +$148K | ﹤0.01% | 2965 |
|
2015
Q3 | $5.5M | Buy |
1,739,845
+828,117
| +91% | +$2.62M | ﹤0.01% | 2924 |
|
2015
Q2 | $5.4M | Buy |
911,728
+54,969
| +6% | +$325K | ﹤0.01% | 2984 |
|
2015
Q1 | $9.16M | Buy |
856,759
+163,613
| +24% | +$1.75M | ﹤0.01% | 2685 |
|
2014
Q4 | $6.51M | Buy |
693,146
+66,443
| +11% | +$624K | ﹤0.01% | 2754 |
|
2014
Q3 | $4.81M | Buy |
626,703
+110,419
| +21% | +$848K | ﹤0.01% | 2844 |
|
2014
Q2 | $4.64M | Buy |
516,284
+53,536
| +12% | +$481K | ﹤0.01% | 2873 |
|
2014
Q1 | $2.48M | Buy |
462,748
+68,000
| +17% | +$364K | ﹤0.01% | 3127 |
|
2013
Q4 | $994K | Buy |
394,748
+772
| +0.2% | +$1.94K | ﹤0.01% | 3418 |
|
2013
Q3 | $1.08M | Buy |
393,976
+106,203
| +37% | +$290K | ﹤0.01% | 3346 |
|
2013
Q2 | $1.04M | Buy |
+287,773
| New | +$1.04M | ﹤0.01% | 3302 |
|